Recon: Lilly to buy Sigilon Therapeutics; FDA adcomm recommends approval of Ipsen’s fibrodysplasia drug
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy